You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology I (MP33)1 Sep 2021MP33-19 TREATMENT OF PROSTATE CANCER USING LASER-IRRADIATED MAGNETOSOMES: A PRE-CLINICAL STUDY Cynthia El Hedjaj, Eric Barret, Imene Chebbi, and Edouard Alphandery Cynthia El HedjajCynthia El Hedjaj More articles by this author , Eric BarretEric Barret More articles by this author , Imene ChebbiImene Chebbi More articles by this author , and Edouard AlphanderyEdouard Alphandery More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002042.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To develop a prostate cancer treatment using laser irradiated bio-synthesized coated iron oxide minerals. METHODS: Nanoparticles used in this study were magnetosomes synthesized by magnetotactic bacteria, extracted and purified from these bacteria. The resulting pure endotoxin free iron oxide minerals were coated with carboxy-methyl-dextran to yield stable coated magnetosome minerals (M-CMD). In vivo experiments followed the Charles Darwin ethical guidelines. Treatment efficacy was tested on 4 groups of 10 mice bearing PC3-Luc tumours of∼100 mm3. Mice received isotonic solution (group 1), 30 µg per mm3 of tumour of M-CMD (group 2), the same condition as in group 2 followed by 10 sessions of 10 minutes of laser radiation of intensity 1.5 W/cm2 and excitation wavelength 808 nm (group 3), isotonic solution followed by the same irradiation as in group 3 (group 4). The evolution of the tumour following treatments was followed by measurements of tumour volumes with a calliper and of tumour Bioluminescence intensity (BLI). Histological studies were carried out using Hematoxylin-Eosin/Pearl staining on tissues located in the region of the initial tumour following the various treatments. RESULTS: In group 3, each session led to a temperature of 45°C for 10 minutes. In 50% of mice belonging to group 3, tumour volume decreased to 0mm3, tumour became un-palpable, and tumour BLI signal was undetectable 12 days following M-CMD administration. No tumour re-growth was observed during the 48 following days, suggesting full disappearance of the treated primary tumour for 50% of the mice in group 3. Histological analysis of tissues collected after the different hyperthermia sessions revealed magnetosome cellular internalization, tumour cell apoptosis and necrosis, and an increase in the percentage of dead tumour cells with increasing number of hyperthermia sessions. By contrast, in all other groups, tumours grew rapidly, and mice had to be euthanized within one month following isotonic solution/M-CMD injection. CONCLUSIONS: We present an efficient and safe method of prostate tumour treatment, which yields full tumour disappearance by exposing natural coated iron oxide minerals called magnetosomes to moderate tumour heating under laser radiation. Magnetosomes were selectively heated due to a coupling between magnetosome surface plasmon waves and laser light, hence minimizing laser heating outside of the magnetosome region, i.e. within the healthy tissues surrounding the tumour, limiting the risk of side effects. Source of Funding: Nanobacterie 36 bd Flandrin- 75016 PARIS © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e614-e614 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Cynthia El Hedjaj More articles by this author Eric Barret More articles by this author Imene Chebbi More articles by this author Edouard Alphandery More articles by this author Expand All Advertisement Loading ...
Read full abstract